Michel Orsinger

Michel Orsinger

Director/Board Member bei TAKEDA PHARMACEUTICAL COMPANY LIMITED

66 Jahre
Health Technology
Consumer Services
Distribution Services

Profil

Michel Orsinger is currently an Independent Outside Director at Takeda Pharmaceutical Co., Ltd.
since 2016.
He is also a Director at Neo Medical Systems SA since 2020.
Additionally, he serves as a Director at Neo Medical SA and as an Advisor at 4FOx Ventures Partners.
In his former positions, Mr. Orsinger was the President & Chief Executive Officer-OTC Worldwide at Novartis AG in 1990.
From 2004 to 2012, he held the position of President & Chief Executive Officer at Synthes, Inc. He also served as the Chairman of the Global Orthopedics Group at Johnson & Johnson.
Furthermore, he was the Chairman of Limacorporate SpA and Chairman of Johnson & Johnson Services, Inc. Mr. Orsinger was a Non-Executive Director at Nobel Biocare Holding AG and a Director at Nobel Biocare Holding AG from 2004 to 2006.
Mr. Orsinger obtained his undergraduate degree from the University of St. Gallen.

Aktive Positionen von Michel Orsinger

UnternehmenPositionBeginn
TAKEDA PHARMACEUTICAL COMPANY LIMITED Director/Board Member 01.06.2016
Director/Board Member 14.05.2020
Director/Board Member -
Consultant / Advisor -
Alle aktiven Positionen von Michel Orsinger

Ehemalige bekannte Positionen von Michel Orsinger

UnternehmenPositionEnde
President 01.01.2012
NOBEL BIOCARE HOLDING AG Director/Board Member 01.01.2006
NOVARTIS AG President 02.01.1990
Chairman -
JOHNSON & JOHNSON Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Michel Orsinger im Detail an

Ausbildung von Michel Orsinger

University of St. Gallen Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Michel Orsinger im Detail an

Beziehungen

81

Beziehungen ersten Grades

11

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
JOHNSON & JOHNSON

Health Technology

NOVARTIS AG

Health Technology

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Health Technology

Private Unternehmen7

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Finance

Technology Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Michel Orsinger